Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 5

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 5
---
 proceeds received by us, and investors in this offering will not receive a refund if we do not sell all of the securities offered hereby.
In addition, because there is no escrow account and no minimum number of securities or amount of proceeds, investors could be in a position
where they have invested in us, but we have not raised sufficient proceeds in this offering to adequately fund the intended uses of the
proceeds as described in this prospectus.

|                                    | Per Share |     | Per Pre-Funded Warrant |     | Warrant |     | Total |
|:-----------------------------------|:----------|:----|:-----------------------|:----|:--------|:----|:------|
| Public offering price              | $         |     | $                      |     | $       |     | $     |
| Placement agent fees(1)            | $         |     | $                      |     | $       |     | $     |
| Proceeds, before expenses to us(2) | $         |     | $                      |     | $       |     | $     |

| (1) | We have agreed to (i) pay the placement agent a cash fee equal to 6.5% of the aggregate gross proceeds raised at the closing of this offering and (ii) issue warrants to the placement agent exercisable for a number of shares of common stock equal to 4.0% of the total number of shares of common stock issued in this offering. We have also agreed to reimburse the placement agent for certain expenses and closing costs. See “Plan of Distribution” for additional information and a description of the compensation payable to the placement agent. |
| (2) | Because there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual public offering amount, placement agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above. For more information, see “Plan of Distribution.”                                                                                                                                                                      |

An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks and uncertainties described in the section captioned “Risk Factors” contained herein and in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 filed with the Securities and Exchange Commission (the SEC) on June 26, 2025, and other filings we make with the SEC from time to